Mobilizar: Capturing User Behavior with Mobile Digital Diaries

In this paper we present Mobilizar, a web-based mobile tool that facilitates the implementation and data collection of self-reported user behavior. Mobilizar was designed with both the researcher and the participant in mind. It provides investigators with a way to setup a new diary study in a matter of minutes and to electronically collect diary data from participants by using internet-enabled mobile devices. These devices promise to alleviate the burden of carrying a paper-and-pencil diary by instead using the participant’s own device. It also gives participants the flexibility to report their behavior in different ways such as making text, voice, or picture entries that fit their current situational constraints. In this paper, we describe the user interface design of Mobilizar and how it may be used to conduct diary studies with mobile devices

Challenges of Corn Stover Transportation

Stover has the potential to be a very useful byproduct of corn. Corn stover uses: Feedstock for cellulosic ethanol; Fuel source for power plants; Animal bedding. Benefits of corn stover: Inexpensive; Readily available in Iowa. Who can stover benefit? Farmers who can make money by selling stover; Buyers have access to cheap, eco-friendly material

Challenges of Corn Stover Transportation

Stover has the potential to be a very useful byproduct of corn. Corn stover uses: Feedstock for cellulosic ethanol; Fuel source for power plants; Animal bedding. Benefits of corn stover: Inexpensive; Readily available in Iowa. Who can stover benefit? Farmers who can make money by selling stover; Buyers have access to cheap, eco-friendly material.</p

Mail2Wiki: Low-Cost Sharing and Early Curation from Email to Wikis. Proc of C&amp;T,

ABSTRACT In this design paper we motivate and describe the Mail2Wiki system, which enables low-cost sharing and early curation from email to wikis by knowledge workers. We aim to aid adoption of enterprise wikis and enable more efficient knowledge sharing and reuse. We present a design rationale grounded in prior empirical work, the design of the system, and the evaluation of the user interface. The system includes two alternative front-ends to enable incremental adoption by workers who are currently using email to share with their communities

Lupus community panel proposals for optimising clinical trials: 2018.

Formidable impediments stand in the way of treatment development for lupus. These include the unwieldy size of current trials, international competition for scarce patients, complex outcome measures and a poor understanding of these outcomes in the world at large. The heterogeneity of the disease itself coupled to superimposition of variegated background polypharmacy has created enough immunological noise to virtually ensure the failure of lupus treatment trials, leaving an understandable suspicion that at least some of the results in testing failed drugs over the years may not have been negative, but merely uninterpretable. The authors have consulted with many clinical trial investigators, biopharmaceutical developers and stakeholders from government and voluntary sectors. This paper examines the available evidence that supports workable trial designs and proposes approaches to improve the odds of completing interpretable treatment development programs for lupus

Lupus community panel proposals for optimising clinical trials:2018

Formidable impediments stand in the way of treatment development for lupus. These include the unwieldy size of current trials, international competition for scarce patients, complex outcome measures and a poor understanding of these outcomes in the world at large. The heterogeneity of the disease itself coupled to superimposition of variegated background polypharmacy has created enough immunological noise to virtually ensure the failure of lupus treatment trials, leaving an understandable suspicion that at least some of the results in testing failed drugs over the years may not have been negative, but merely uninterpretable. The authors have consulted with many clinical trial investigators, biopharmaceutical developers and stakeholders from government and voluntary sectors. This paper examines the available evidence that supports workable trial designs and proposes approaches to improve the odds of completing interpretable treatment development programs for lupus